Biopharm Business - BioPharm International


Biopharm Business
Insight and analysis to business aspects of biopharmaceutical development. Mergers, acquisitions, legal activities.

Patheon to Merge with DSM Pharmaceutical Products

November 19, 2013

New CDMO to be formed from the combination of DSM Pharmaceutical Products and Patheon in a $2.6-billion transaction.

Navigating Emerging Markets: Middle East and North Africa

October 1, 2013

The pharmaceutical industry grows despite conflict in the Middle East.

Report from Myanmar

October 1, 2013

Foreign companies zero in on Myanmar with the hope of securing a foothold in its pharmaceutical market.

Robust IPO Market for Life Sciences Sparks Change Among Investors

October 1, 2013

Early-stage companies are now embraced by buyers of new issues.

Angiopoietins: Novel Targets for Anti-angiogenesis Therapy

October 1, 2013

The authors review the angiopoietin pathway as an alternative for safer and more efficacious anti-angiogenic therapeutics.

Report from Brazil

September 1, 2013

Pharma eyes biologics production in Brazil as the government begins to recognize the potential of these drugs.

Oncobiologics, inVentiv Health Partner for Biosimilars Development

August 6, 2013

Oncobiologics, Inc. and inVentiv Health announced a global strategic partnership around clinical development for all assets in Oncobiologic?s biosimilar pipeline.

Report from India

August 1, 2013

Industry players brace themselves to face challenges as India's new drug-pricing policy kicks in full gear.

Pharma Invests in Gene Therapy Programs

August 1, 2013

Pharmaceutical companies have stepped up gene therapy development in the wake of the approval of Glybera in 2012.



Click here